1. Home
  2. CLDX vs PRVA Comparison

CLDX vs PRVA Comparison

Compare CLDX & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$42.66

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Privia Health Group Inc.

PRVA

Privia Health Group Inc.

HOLD

Current Price

$21.46

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
PRVA
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
CLDX
PRVA
Price
$42.66
$21.46
Analyst Decision
Strong Buy
Buy
Analyst Count
10
12
Target Price
$46.60
$31.17
AVG Volume (30 Days)
963.5K
1.3M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
63.64
EPS
N/A
0.09
Revenue
$12,743,000.00
$2,122,842,000.00
Revenue This Year
$111.39
$18.19
Revenue Next Year
$235.85
$10.72
P/E Ratio
N/A
$244.44
Revenue Growth
87.78
22.26
52 Week Low
$20.37
$19.53
52 Week High
$45.14
$28.82

Technical Indicators

Market Signals
Indicator
CLDX
PRVA
Relative Strength Index (RSI) 63.24 30.59
Support Level $28.51 $21.20
Resistance Level N/A $24.65
Average True Range (ATR) 1.71 0.81
MACD 0.24 -0.22
Stochastic Oscillator 72.23 36.08

Price Performance

Historical Comparison
CLDX
PRVA

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About PRVA Privia Health Group Inc.

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

Share on Social Networks: